- Home
- BTMD vs ATRA Comparison
BTMD vs ATRA Comparison
Compare BTMD & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTMD | ATRA |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.6M | 99.1M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BTMD | ATRA |
|---|---|---|
| Price | $2.55 | $14.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $6.00 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 144.2K | 63.3K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 270.48 | N/A |
| EPS | 0.78 | ★ 1.97 |
| Revenue | ★ $195,645,000.00 | $151,930,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.80 | N/A |
| P/E Ratio | ★ $3.27 | $7.29 |
| Revenue Growth | 1.34 | ★ 51.27 |
| 52 Week Low | $2.32 | $5.01 |
| 52 Week High | $6.90 | $18.71 |
Technical Indicators
Market Signals| Indicator | BTMD | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 53.90 |
| Support Level | $2.32 | $12.05 |
| Resistance Level | $2.61 | $15.12 |
| Average True Range (ATR) | 0.14 | 1.06 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 54.02 | 70.59 |
Price Performance
Historical ComparisonAbout BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).